225
Views
7
CrossRef citations to date
0
Altmetric
Articles

OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients

, MD, , MD, , MD & , MD
Pages 315-322 | Received 22 Jun 2015, Accepted 04 Feb 2016, Published online: 12 Apr 2016

REFERENCES

  • Lutton JD, Winston R, Rodman TC. Multiple sclerosis: etiological mechanisms and future directions. Exp Biol Med. 2004;229:12–20.
  • Fairless R, Williams SK, Hoffmann DB, et al. Preclinical retinal neurodegeneration in a model of multiple sclerosis. J Neurosci. 2012;32:5585–5597.
  • Bock M, Paul F, Dörr J. Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography. Nervenarzt. 2013;84:483–492.
  • Vidal-Jordana Á, Sastre-Garriga J Montalban X. Optical coherence tomography in multiple sclerosis. Rev Neurol. 2012;54:556–563.
  • McDonald WI, Compston DAS, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127.
  • Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald criteria’. Ann Neurol. 2005;58:840–846.
  • Funaki S, Shirakashi M, Funaki H, et al. Relationship between age and the thickness of the retinal nerve fiber layer in normal subjects. Jpn J Ophthalmol. 1999;43:180–185.
  • Budenz DL, Anderson DR, Varma R, et al. Determinants of normal retinal nerve fiber layer thickness measured by stratus OCT. Ophthalmology. 2007;114:1046–1052.
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452.
  • Voss E, Raab P, Trebst C, et al. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord. 2011;4:123–134.
  • Tewarie P, Balk L, Costello F, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE. 2012;7:e34823.
  • Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007;17:210–218.
  • Burkholder BM, Osborne B, Loguidice MJ, et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol. 2009;66:1366–1372.
  • Klistorner A, Arvind H, Nguyen T, et al. Axonal loss and myelin in early on loss in postacute optic neuritis. Ann Neurol. 2008;64:325–331.
  • Ghalie AA, Husein TR. Study of retinal nerve fiber layer thickness in multiple sclerosis by using optical coherence tomography. Egypt J Neurol Psychiatr Neurosurg. 2010;47:497–504.
  • Oberwahrenbrock T, Schippling S, Ringelstein M, et al. Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int [internet]. 2012;10. Available at: http://dx.doi.org/10.1155/2012/530305. Accessed September 13, 2014.
  • Noval S, Contreras I, Mửnoz S, et al. Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update. Mult Scler Int [internet]. 2011;11. Available at: http://dx.doi.org/10.1155/2011/472790. Accessed November 22, 2014.
  • Syc SB, Saidha S, Newsome SD, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012;135:521–533.
  • Davies EC, Galetta KM, Sackel DJ, et al. Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol. 2011;31:260–264.
  • Khanifar AA, Parlitsis GJ, Ehrlich JR, et al. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol. 2010;4(1): 1007–1013.
  • Serbecic N, Beutelspacher SC, Kircher K, et al. Interpretation of RNFLT values in multiple sclerosis-associated acute optic neuritis using high resolution SD-OCT device. Acta Ophthalmol. 2012;90:540–545.
  • Fjeldstad C, Bemben M, Pardo G. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography. J Clin Neurosci. 2011;18:1469–1472.
  • Pueyo V, Ara JR, Almarcegui C, et al. Subclinical atrophy of the retinal nerve fiber layer in multiple sclerosis. Acta Ophthalmol. 2010;88:748–752.
  • Gundogan FC, Demirkaya S, Sobaci G. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis? A structural and functional evaluation. Invest Ophthalmol Vis Sci. 2007;48:5773–5781.
  • Siepman AM, Bettink-Remeijer MW, Hintzen RQ. Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry. J Neurol. 2010;257:1654–1660.
  • Pulicken M, Gordon-Lipkin E, Balcer LJ, et al. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology. 2007;69:2085–2092.
  • Costello F, Hodge W, Pan YI, et al. Using retinal architecture to help characterize multiple sclerosis patients. Can J Ophthalmol. 2010;45:520–526.
  • Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology. 2009;72:1077–1082.
  • Kaufhold F, Zimmermann H, Schneider E, et al. Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One. 2013;8:e71145.
  • Green AJ, McQuaid S, Hauser SL, et al. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010;133:1591–1601.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.